Lansoprazole Capsule, Delayed Release
Product Images NDC 46122-744

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 46122-744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amerisourcebergen Drug Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Amerisource Lanso Caps 14ct Carton)

Lansoprazole delayed-release capsules USP, 15 mg, acid reducer, labeler AmerisourceBergen Drug Corporation, containing 14 capsules. The label includes coverage for frequent heartburn treatment, dosage directions, warnings, inactive ingredients, and tips for managing heartburn. The packaging compares this product to Prevacid 24 HR and includes the NDC 46122-744-74.*

FDA Label Image

Label (Amerisource Lanso Caps 14ct Label)

Lansoprazole 15 mg delayed-release capsules label from AmerisourceBergen Drug Corporation. The label indicates the product is an acid reducer for treating frequent heartburn with a 14-capsule, one 14-day course of treatment. Directions, warnings, and manufacturer details are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.